Abstract
We herein report the clinical and laboratory characteristics of two anti-OJ (anti-isoleucyl-tRNA synthetase) autoantibody-positive interstitial lung disease patients with polymyositis/dermatomyositis (PM/DM). We compared these characteristics with previously published findings. Previous reports and our present cases show that anti-OJ autoantibody-positive interstitial lung disease (ILD) patients with PM/DM lack the manifestations of Raynaud's phenomenon and sclerodactyly and show good prognoses and responses to glucocorticoid therapy. These results indicate that the presence of anti-OJ autoantibodies may be useful for predicting the prognosis of ILD and its clinical course in PM/DM patients. © 2012, The Japanese Society of Internal Medicine. All rights reserved.
Author supplied keywords
Cite
CITATION STYLE
Kunimasa, K., Arita, M., Nakazawa, T., Tanaka, M., Tsubouchi, K., Konishi, S., … Ishida, T. (2012). The Clinical Characteristics of Two Anti-OJ (Anti-Isoleucyl-tRNA Synthetase) Autoantibody-Positive Interstitial Lung Disease Patients with Polymyositis/Dermatomyositis. Internal Medicine, 51(24), 3405–3410. https://doi.org/10.2169/internalmedicine.51.7452
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.